or Try an Advanced Search...

    Advanced Solid Tumors Stocks List

    Symbol Grade Name % Change
    CRDF B Cardiff Oncology, Inc. 2.72
    CASI C CASI Pharmaceuticals, Inc. -0.41
    HOWL C Werewolf Therapeutics, Inc. -2.94
    IMRX D Immuneering Corporation 0.54
    SLRX F Salarius Pharmaceuticals, Inc. -8.07
    ADCT F ADC Therapeutics SA 4.61
    CLRB F Cellectar Biosciences, Inc. -0.49
    STTK F Shattuck Labs, Inc. -0.79
    ELEV F Elevation Oncology, Inc. -6.67
    RLAY F Relay Therapeutics, Inc. 3.64
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Cancer Solid Tumors Biotechnology Clinical Medicine Life Sciences Medicine Oncology Treatment Of Cancer Antineoplastic Drugs Biopharmaceutical Cancer Treatment Lymphoma Ovarian Cancer Autoimmune Disease Chemotherapy Health Sciences Leukemia Metastatic Solid Tumors Pharmaceutical Prostate Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.07
    LRNZ B TrueMark Technology, AI & Deep Learning ETF 1.05
    CANC C Tema Oncology ETF 0.76
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.62
    SCDS B JPMorgan Fundamental Data Science Small Core ETF 0.34
    View all Advanced Solid Tumors ETFs...
    Compare ETFs
    Compare CANC to BBC Compare CNCR to SCDS Compare LRNZ to CANC

        Advanced Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 1 CLRB Cellectar Biosciences regains compliance with Nasdaq
        Nov 1 CLRB Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q
        Nov 1 ADCT Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
        Oct 31 HOWL Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINE™ Molecule for Inflammatory Diseases
        Oct 31 ADCT ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
        Oct 30 CRDF Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC
        Oct 30 RLAY Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024
        Oct 28 RLAY Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses
        Oct 28 ADCT Institutional investors own a significant stake of 32% in ADC Therapeutics SA (NYSE:ADCT)
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Solid Tumors Cancer Clinical Medicine Medicine Biotechnology Oncology Antineoplastic Drugs Biopharmaceutical Cancer Treatment Life Sciences Treatment Of Cancer Chemotherapy Drugs Health Sciences Leukemia Lymphoma Metastatic Solid Tumors Ovarian Cancer Pharmaceutical Prostate Cancer
        Advanced Solid Tumors

        Advanced solid tumors are cancerous tumors that have spread beyond the original site of the tumor and have become more difficult to treat. These tumors are often referred to as metastatic or stage IV tumors. Advanced solid tumors can affect any part of the body and can be caused by a variety of different types of cancer. Treatment options for advanced solid tumors may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and/or clinical trials.

        Browse All Tags